Bagneux, France

Genomic Vision

Calculating rank
USPTO Granted Patents = 6

% Expired Patents = 50.0


Forward Citations = 3

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Pierre Walrafen (4 out of 4 patents)

silverMedal Aaron Bensimon (4 out of 23 patents)

bronzeMedal Maurizio Ceppi (2 out of 2 patents)

4.  Emmanuel Conseiller (2 out of 5 patents)

5.  Ronald Lebofsky (2 out of 2 patents)

6.  Sylvain Berlemont (1 out of 3 patents)

7.  Jennifer Abscheidt (1 out of 1 patent)

8.  Etienne Rouleau (1 out of 1 patent)

9.  Nicolas Levy (1 out of 5 patents)

10.  Anne Vannier (1 out of 1 patent)

11.  Jun Komatsu (1 out of 1 patent)

12.  Jean-Christophe Olivo-Marin (1 out of 2 patents)

13.  Sébastien Barradeau (1 patent)

14.  Fabrice Salvaire (0 patent)

15.  Lucia Cinque (0 patent)


6 patents:

Company Overview
Genomic Vision is a biotechnology company specialized in the development of innovative diagnostic tools for the early detection of genetic diseases. The company's proprietary technology allows for the direct visualization of the genome, enabling the identification of genetic abnormalities with unprecedented accuracy. Genomic Vision's solutions are used by researchers and healthcare professionals worldwide to improve patient outcomes through personalized medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#8 in Bagneux

#2,491 in France

Bagneux, FR
Bagneux, France
Forward Citations = 3

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genomic Vision. Retrieved from https://idiyas.com/company/genomic-vision

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…